Published in J Virol on August 01, 1994
Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol (2001) 6.71
Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol (2001) 6.37
Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J Virol (2001) 4.86
Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J Virol (2000) 2.89
Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells. J Virol (2001) 2.77
Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J Virol (1995) 2.76
De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus. J Virol (2000) 2.65
Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. J Virol (1994) 2.64
In vitro selection and characterization of hepatitis C virus serine protease variants resistant to an active-site peptide inhibitor. J Virol (2003) 2.55
Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation. J Virol (1995) 2.29
A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro. J Virol (1995) 2.26
Modulation of hepatitis C virus NS5A hyperphosphorylation by nonstructural proteins NS3, NS4A, and NS4B. J Virol (1999) 2.26
Protein-protein interactions between hepatitis C virus nonstructural proteins. J Virol (2003) 2.23
Bovine viral diarrhea virus NS3 serine proteinase: polyprotein cleavage sites, cofactor requirements, and molecular model of an enzyme essential for pestivirus replication. J Virol (1997) 2.00
Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics. PLoS Pathog (2009) 1.94
Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form. Protein Sci (1998) 1.90
Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J Virol (2006) 1.87
Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant. J Virol (2007) 1.87
Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitro. Antimicrob Agents Chemother (2004) 1.87
Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032). Antimicrob Agents Chemother (2012) 1.85
An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A. J Virol (1995) 1.78
Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitro. Antimicrob Agents Chemother (2005) 1.75
Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B, and NS5A encoded on the same polyprotein. J Virol (1999) 1.75
Nonstructural protein precursor NS4A/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus. J Virol (2003) 1.62
The NS2 protein of hepatitis C virus is a transmembrane polypeptide. J Virol (1995) 1.61
Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus. J Virol (1998) 1.54
Hepatitis C virus-encoded NS2-3 protease: cleavage-site mutagenesis and requirements for bimolecular cleavage. J Virol (1995) 1.49
A conserved NS3 surface patch orchestrates NS2 protease stimulation, NS5A hyperphosphorylation and HCV genome replication. PLoS Pathog (2015) 1.46
Hepatitis C virus NS2 coordinates virus particle assembly through physical interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes. J Virol (2010) 1.43
Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line. J Virol (2005) 1.41
An overview of HCV molecular biology, replication and immune responses. Virol J (2011) 1.37
Relation between viral fitness and immune escape within the hepatitis C virus protease. Gut (2005) 1.33
Activity of purified hepatitis C virus protease NS3 on peptide substrates. J Virol (1996) 1.32
The C terminus of hepatitis C virus NS4A encodes an electrostatic switch that regulates NS5A hyperphosphorylation and viral replication. J Virol (2007) 1.32
Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase. J Virol (1995) 1.31
Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease. J Virol (1996) 1.31
The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay. Proc Natl Acad Sci U S A (1995) 1.30
Protease inhibitors as antiviral agents. Clin Microbiol Rev (1998) 1.25
Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected COS cells. J Virol (1997) 1.25
The hepatitis C virus NS4A protein: interactions with the NS4B and NS5A proteins. J Virol (1997) 1.23
The N-terminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A. J Virol (1995) 1.21
In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450. Antimicrob Agents Chemother (2014) 1.20
In vitro study of the NS2-3 protease of hepatitis C virus. J Virol (1997) 1.18
Specific interaction of hepatitis C virus protease/helicase NS3 with the 3'-terminal sequences of viral positive- and negative-strand RNA. J Virol (2001) 1.15
Hepatitis C virus NS2 is a protease stimulated by cofactor domains in NS3. Proc Natl Acad Sci U S A (2009) 1.14
Bovine viral diarrhea virus: characterization of a cytopathogenic defective interfering particle with two internal deletions. J Virol (1996) 1.13
Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin beta3. J Virol (2000) 1.09
Probing the substrate specificity of hepatitis C virus NS3 serine protease by using synthetic peptides. J Virol (1997) 1.07
The protease domain increases the translocation stepping efficiency of the hepatitis C virus NS3-4A helicase. J Biol Chem (2010) 1.06
Hepatitis G virus encodes protease activities which can effect processing of the virus putative nonstructural proteins. J Virol (1998) 1.06
NS3-4A of hepatitis C virus is a chymotrypsin-like protease. J Virol (1995) 1.06
Antisense oligonucleotides targeted to the domain IIId of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translation. Nucleic Acids Res (2003) 1.06
Molecular mechanisms of viral and host cell substrate recognition by hepatitis C virus NS3/4A protease. J Virol (2011) 1.05
Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein. Virology (2013) 1.01
Biosynthesis of classical swine fever virus nonstructural proteins. J Virol (2011) 1.00
The Hepatitis C Virus NS5A Stimulates NS5B During In Vitro RNA Synthesis in a Template Specific Manner. Open Biochem J (2009) 1.00
The acidic domain of hepatitis C virus NS4A contributes to RNA replication and virus particle assembly. J Virol (2010) 1.00
The NS3 proteinase domain of hepatitis C virus is a zinc-containing enzyme. J Virol (1997) 0.99
Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner. J Virol (2010) 0.99
Selection of replicon variants resistant to ACH-806, a novel hepatitis C virus inhibitor with no cross-resistance to NS3 protease and NS5B polymerase inhibitors. Antimicrob Agents Chemother (2008) 0.99
Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0. J Virol (2012) 0.96
Conserved C-terminal threonine of hepatitis C virus NS3 regulates autoproteolysis and prevents product inhibition. J Virol (2004) 0.96
Protective immunity against hepatitis C: many shades of gray. Front Immunol (2014) 0.94
Differential requirements of NS4A for internal NS3 cleavage and polyprotein processing of hepatitis C virus. J Virol (2007) 0.89
Antisense oligonucleotide inhibition of hepatitis C virus (HCV) gene expression in livers of mice infected with an HCV-vaccinia virus recombinant. Antimicrob Agents Chemother (1999) 0.88
Autocatalytic cleavage within classical swine fever virus NS3 leads to a functional separation of protease and helicase. J Virol (2013) 0.87
Hepatitis C virus NS3 protein can activate the Notch-signaling pathway through binding to a transcription factor, SRCAP. PLoS One (2011) 0.87
Increasing rate of cleavage at boundary between non-structural proteins 4B and 5A inhibits replication of hepatitis C virus. J Biol Chem (2011) 0.87
Establishment of a simple assay in vitro for hepatitis C virus NS3 serine protease based on recombinant substrate and single-chain protease. World J Gastroenterol (2002) 0.86
Computer aided screening of Accacia nilotica phytochemicals against HCV NS3/4a. Bioinformation (2013) 0.85
Efficiency of E2-p7 processing modulates production of infectious hepatitis C virus. J Virol (2013) 0.85
Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase. Bioorg Med Chem (2010) 0.84
In vivo selection of protease cleavage sites by using chimeric Sindbis virus libraries. J Virol (2000) 0.83
The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients. Clin Mol Hepatol (2014) 0.83
NS5A Domain 1 and Polyprotein Cleavage Kinetics Are Critical for Induction of Double-Membrane Vesicles Associated with Hepatitis C Virus Replication. MBio (2015) 0.82
Complete translation of the hepatitis C virus genome in vitro: membranes play a critical role in the maturation of all virus proteins except for NS3. J Virol (2005) 0.82
Selection of functional variants of the NS3-NS4A protease of hepatitis C virus by using chimeric sindbis viruses. J Virol (1999) 0.82
Cell culture replication of a genotype 1b hepatitis C virus isolate cloned from a patient who underwent liver transplantation. PLoS One (2011) 0.81
Humanized-VHH transbodies that inhibit HCV protease and replication. Viruses (2015) 0.80
The characteristics of rare codon clusters in the genome and proteins of hepatitis C virus; a bioinformatics look. Middle East J Dig Dis (2014) 0.79
Discovering novel anti-HCV compounds with inhibitory activities toward HCV NS3/4A protease. Acta Pharmacol Sin (2014) 0.79
Telaprevir/boceprevir era: from bench to bed and back. World J Gastroenterol (2012) 0.79
Isolation and characterization of monoclonal antibodies that inhibit hepatitis C virus NS3 protease. J Virol (2000) 0.79
Degradation of AIMP1/p43 induced by hepatitis C virus E2 leads to upregulation of TGF-β signaling and increase in surface expression of gp96. PLoS One (2014) 0.78
Specific targeting of hepatitis C virus core protein by an intracellular single-chain antibody of human origin. Hepatology (2008) 0.78
Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E. J Virol (2017) 0.77
Serine 235 Is the Primary NS5A Hyper-Phosphorylation Site Responsible for HCV Replication. J Virol (2017) 0.76
Curation of viral genomes: challenges, applications and the way forward. BMC Bioinformatics (2006) 0.76
Human Transbodies to HCV NS3/4A Protease Inhibit Viral Replication and Restore Host Innate Immunity. Front Immunol (2016) 0.76
Molecular screening of phytochemicals from Amelanchier Alnifolia against HCV NS3 protease/helicase using computational docking techniques. Bioinformation (2013) 0.76
Analysis of the Enzymatic Activity of an NS3 Helicase Genotype 3a Variant Sequence Obtained from a Relapse Patient. PLoS One (2015) 0.75
Compensatory substitutions in the HCV NS3/4A protease cleavage sites are not observed in patients treated unsuccessfully with telaprevir combination treatment. Virol J (2012) 0.75
Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target. PLoS One (2014) 0.75
The Discovery and Development of Boceprevir: A Novel, First-generation Inhibitor of the Hepatitis C Virus NS3/4A Serine Protease. J Clin Transl Hepatol (2013) 0.75
Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. World J Gastroenterol (2007) 0.75
The uncoupling of protease trans-cleavage and helicase activities in the pestivirus NS3. J Virol (2017) 0.75
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 37.89
Flavivirus genome organization, expression, and replication. Annu Rev Microbiol (1990) 14.20
Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A (1990) 9.98
Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci U S A (1990) 8.92
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol (1993) 8.07
Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology (1991) 7.33
Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci U S A (1991) 7.15
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 6.96
Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol (1993) 6.36
Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol (1993) 5.41
Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol (1991) 4.63
NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol (1993) 4.60
Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol (1993) 4.57
A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci U S A (1993) 4.30
Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proc Natl Acad Sci U S A (1990) 4.12
Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci U S A (1993) 3.68
In vitro processing of dengue virus type 2 nonstructural proteins NS2A, NS2B, and NS3. J Virol (1990) 3.50
Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet (1989) 3.42
Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites. J Virol (1991) 3.41
Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J Virol (1993) 3.37
At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci U S A (1993) 3.37
Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol (1993) 3.18
Pestivirus gene expression: protein p80 of bovine viral diarrhea virus is a proteinase involved in polyprotein processing. Virology (1991) 3.06
The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. Biochem Biophys Res Commun (1993) 2.67
Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells. Virology (1992) 2.58
Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain. Virology (1993) 2.34
Cleavage of the dengue virus polyprotein at the NS3/NS4A and NS4B/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A/NS4B may be processed by a cellular protease. J Virol (1992) 2.33
Molecular genetics of pestiviruses. Comp Immunol Microbiol Infect Dis (1992) 2.21
Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proc Natl Acad Sci U S A (1992) 2.18
Expression of processed core protein of hepatitis C virus in mammalian cells. J Virol (1991) 1.91
Expression of processed envelope protein of hepatitis C virus in mammalian and insect cells. J Virol (1992) 1.68
Expression of the P-protein of the human hepatitis B virus in a vaccinia virus system and detection of the nucleocapsid-associated P-gene product by radiolabelling at newly introduced phosphorylation sites. Nucleic Acids Res (1992) 1.50
Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res (1991) 1.27
Characterization of hepatitis C virus structural proteins with a recombinant baculovirus expression system. Hepatology (1993) 1.19
Iron increases ethanol toxicity in rat liver. J Hepatol (1993) 1.00
Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol (1993) 4.57
Identification of amino acid residues critical for endonuclease and integration activities of HIV-1 IN protein in vitro. Virology (1992) 3.43
Bacterial transcript imaging by hybridization of total RNA to oligonucleotide arrays. Nat Biotechnol (1998) 3.29
Antiviral effects of recombinant tumour necrosis factor in vitro. Nature (1986) 3.25
Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat Genet (2000) 2.71
HIV-1 RT-associated ribonuclease H displays both endonuclease and 3'----5' exonuclease activity. EMBO J (1990) 2.54
Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J Neurosci (2000) 2.49
In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies. J Infect Dis (1996) 2.34
Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959. Virology (1995) 2.29
Open Pulled Straw (OPS) vitrification: a new way to reduce cryoinjuries of bovine ova and embryos. Mol Reprod Dev (1998) 2.01
Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Am J Pathol (2001) 1.81
Processing and nucleo-cytoplasmic transport of histone gene transcripts. Nucleic Acids Res (1984) 1.80
Active site mutagenesis of the AIDS virus protease and its alleviation by trans complementation. EMBO J (1988) 1.80
The N-terminal amino-acid sequences of DNA polymerase I from Escherichia coli and of the large and the small fragments obtained by a limited proteolysis. Eur J Biochem (1974) 1.67
Hepatitis C virus core protein: carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase. Virology (1996) 1.60
Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription. Virology (1988) 1.55
Expression of biologically active human T-cell lymphotropic virus type III reverse transcriptase in Bacillus subtilis. Gene (1987) 1.43
Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci U S A (1998) 1.38
The complete amino acid sequence of prochymosin. Proc Natl Acad Sci U S A (1977) 1.32
Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase. J Virol (1995) 1.31
Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2',5'-adenylate synthetase. J Gen Virol (1988) 1.26
Purification and characterization of a protein from porcine gut with glucagon-like immunoreactivity. Horm Metab Res (1976) 1.23
Regulation of ppp(A2'p)nA-dependent RNase levels during interferon treatment and cell differentiation. Eur J Biochem (1985) 1.19
A mouse cell line, which is unprotected by interferon against lytic virus infection, lacks ribonuclease F activity. Eur J Biochem (1981) 1.16
Amyloidogenic function of the Alzheimer's disease-associated presenilin 1 in the absence of endoproteolysis. Biochemistry (1999) 1.16
A single 66-kilodalton polypeptide processed from the human immunodeficiency virus type 2 pol polyprotein in Escherichia coli displays reverse transcriptase activity. J Virol (1988) 1.15
Comparison of the human immunodeficiency virus type 1 and 2 proteases by hybrid gene construction and trans-complementation. J Biol Chem (1989) 1.13
Severe immunodeficiency associated with a human immunodeficiency virus 1 NEF/3'-long terminal repeat transgene. J Exp Med (1994) 1.13
Interferon-induced synthesis of 2-5A-dependent RNase in mouse JLS-V9R cells. Virology (1983) 1.10
Emergence of resistant variants of HIV in vivo during monotherapy with the proteinase inhibitor saquinavir. J Antimicrob Chemother (1997) 1.09
Presenilins are processed by caspase-type proteases. J Biol Chem (1997) 1.08
Stimulation of sea urchin H2B histone gene transcription by a chromatin-associated protein fraction depends on gene sequences downstream of the transcription start site. Mol Cell Biol (1985) 1.07
Glicentin immunoreactive cells: their relationship to glucagon-producing cells. Endocrinology (1979) 1.06
Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity. Antiviral Res (1996) 1.04
Glyceraldehyde-3-phosphate dehydrogenase is a nonhistone protein and a possible activator of transcription in neurons. J Neurochem (1986) 1.03
Identification of an amino acid substitution involved in the reduction of sensitivity of HIV-1 to an inhibitor of viral proteinase. Acta Virol (1994) 1.02
Conserved residues Pro-109 and Asp-116 are required for interaction of the human immunodeficiency virus type 1 integrase protein with its viral DNA substrate. J Virol (1993) 1.01
Purification and characterisation of prostatic binding protein and its subunits. Eur J Biochem (1978) 1.00
Induction of ppp(A2'p)nA-dependent RNase in murine JLS-V9R cells during growth inhibition. Proc Natl Acad Sci U S A (1983) 1.00
Molecular cloning and characterization of a German HIV-1 isolate. AIDS Res Hum Retroviruses (1990) 0.97
Competitive polymerase chain reaction assay for quantitation of HIV-1 DNA and RNA. J Virol Methods (1992) 0.96
Different effects of IFN gamma and IFN alpha/beta on "immediate early" gene expression of HSV-1. Virology (1990) 0.96
Progression of early steps of human immunodeficiency virus type 1 replication in the presence of an inhibitor of viral protease. J Virol (1992) 0.96
Sequence analysis of porcine gut GLI-1. Biochim Biophys Acta (1977) 0.94
CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients. J Immunol (1992) 0.92
Caspase-mediated cleavage is not required for the activity of presenilins in amyloidogenesis and NOTCH signaling. Neuroreport (1998) 0.90
Mutation of conserved N-glycosylation sites around the CD4-binding site of human immunodeficiency virus type 1 GP120 affects viral infectivity. Virus Res (1990) 0.89
Antiviral activity of prostaglandin A on encephalomyocarditis virus-infected cells: a unique effect unrelated to interferon. J Gen Virol (1985) 0.88
Structure-function relationship: immunologic. Metabolism (1976) 0.88
Purification and in vitro-phospholabeling of secretory envelope proteins E1 and E2 of hepatitis C virus expressed in insect cells. Virus Res (1996) 0.88
Inhibition of replication of herpes simplex virus in mouse macrophages by interferons. J Gen Virol (1985) 0.87
Exocrine function in primary Sjögren syndrome: natural course and prognostic factors. Ann Rheum Dis (2007) 0.87
Interruption of rotavirus spread through chemical disinfection. Infect Control Hosp Epidemiol (1994) 0.87
Genomic divergence of an HIV-2 from a German AIDS patient probably infected in Mali. AIDS (1990) 0.86
Chemical disinfection to interrupt transfer of rhinovirus type 14 from environmental surfaces to hands. Appl Environ Microbiol (1993) 0.85
The wheat germ cell-free system possesses processing activity for the precursor of human placental lactogen. Biochim Biophys Acta (1979) 0.85
Alzheimer's disease associated presenilin-1 holoprotein and its 18-20 kDa C-terminal fragment are death substrates for proteases of the caspase family. Biochemistry (1998) 0.84
Synthesis of herpes simplex virus proteins and nucleic acids in interferon-treated macrophages. Virology (1986) 0.84
Full-term development of nuclear transfer calves produced from open-pulled straw (OPS) vitrified cytoplasts: work in progress. Theriogenology (1999) 0.84
The urethral plug: a new treatment modality for genuine urinary stress incontinence in women. J Urol (1990) 0.83
A sensitive immunoenzymometric assay for 2',5'-oligoadenylate. Detection of elevated 2',5'-oligoadenylate synthetase in human peripheral mononuclear cells. J Immunol Methods (1983) 0.83
Clinical, cognitive and functional characteristics of long-stay patients with schizophrenia: a comparison of VA and state hospital patients. Schizophr Res (2000) 0.83
Double-stranded RNA-dependent phosphorylation of protein P1 and eukaryotic initiation factor 2 alpha does not correlate with protein synthesis inhibition in a cell-free system from interferon-treated mouse L cells. Proc Natl Acad Sci U S A (1983) 0.83
Self-efficacy, state anxiety, and cortisol responses to treadmill running. Percept Mot Skills (2001) 0.82
Structural studies on rat prostatic binding protein. The primary structure of its glycosylated component C3. Eur J Biochem (1981) 0.82
An in vitro assay for hepatitis C virus NS3 serine proteinase. Virology (1995) 0.81
Tetracycline-responsive gene expression in mouse brain after amplicon-mediated gene transfer. Gene Ther (1997) 0.81
Sjögren's syndrome in inflammatory rheumatic diseases: analysis of the leukocyte protein calprotectin in plasma and saliva. Scand J Rheumatol (1994) 0.81
Use of a sicca symptoms questionnaire for the identification of patients with Sjögren's syndrome in a heterogeneous hospital population with various rheumatic diseases. Clin Exp Rheumatol (1995) 0.81
Reduced sensitivity to saquinavir: an update on genotyping from phase I/II trials. Antiviral Res (1996) 0.80
Spontaneous spatio-temporal organization in yeast cell suspension. J Cell Sci (1980) 0.80
Blood chemistry, nutrient metabolism, and organ weights in fetal and newborn calves derived from in vitro-produced bovine embryos. Biol Reprod (2000) 0.80
Evaluation of hepatitis C virus envelope proteins expressed in E. coli and insect cells for use as tools for antibody screening. J Hepatol (1997) 0.80
Translation of biologically active messenger RNA from human placenta in Xenopus oocytes. Eur J Biochem (1979) 0.80
Structural studies on rat prostatic binding protein. The primary structure of component C1 from subunit F. Eur J Biochem (1982) 0.79
Applying cognitive response testing in message development and pre-testing. Health Educ Res (2008) 0.79
Description of a new all cause mortality surveillance system in Sweden as a warning system using threshold detection algorithms. Eur J Epidemiol (2006) 0.79
Testicular and glandular contributions to the prolactin pool in human semen. Arch Androl (1985) 0.78
Multiple sclerosis in the Faroe Islands. 7. Results of a case control questionnaire with multiple controls. Acta Neurol Scand (1997) 0.78
Selection and characterization of interferon-sensitive cells derived from an interferon-resistant NIH 3T3 line. J Gen Virol (1987) 0.78
Characterization of high molecular weight plasma protein complexes induced by clotting factor rFXIII-treatment in the cynomolgus monkey. J Thromb Haemost (2007) 0.78
The clinical effect and the effect on serum IgG antibodies to peripheral nerve tissue of plasma exchange in patients wit Guillain-Barré syndrome. J Neurol (1982) 0.77
Spontaneous spatiotemporal organization in yeast extracts. J Biol Chem (1982) 0.77
Synthesis of rat prostatic binding protein in Xenopus oocytes and in wheat germ. Biochem Biophys Res Commun (1977) 0.77
Interferon interactions with thyroid cells. J Interferon Res (1982) 0.77